Essential Nonredundant Function of the Catalytic Activity of Histone Deacetylase 2 in Mouse Development

REFERENCES

• New M, Olzscha H, La Thangue NB. 2012. HDAC inhibitor-based therapies: can we interpret the code? Mol Oncol 6:637–656. http://dx.doi.org/10.1016/j.molonc.2012.09.003.
   PubMed Web of Science ®Google Scholar
• Moser MA, Hagelkruys A, Seiser C. 2014. Transcription and beyond: the role of mammalian class I lysine deacetylases. Chromosoma 123:67–78. http://dx.doi.org/10.1007/s00412-013-0441-x.
   PubMed Web of Science ®Google Scholar
• Alland L, Muhle R, Hou H, Jr, Potes J, Chin L, Schreiber-Agus N, DePinho RA. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49–55. http://dx.doi.org/10.1038/387049a0.
   PubMed Web of Science ®Google Scholar
• Ballas N, Battaglioli E, Atouf F, Andres ME, Chenoweth J, Anderson ME, Burger C, Moniwa M, Davie JR, Bowers WJ, Federoff HJ, Rose DW, Rosenfeld MG, Brehm P, Mandel G. 2001. Regulation of neuronal traits by a novel transcriptional complex. Neuron 31:353–365. http://dx.doi.org/10.1016/S0896-6273(01)00371-3.
   PubMed Web of Science ®Google Scholar
• Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43–48. http://dx.doi.org/10.1038/387043a0.
   PubMed Web of Science ®Google Scholar
• Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349–356. http://dx.doi.org/10.1016/S0092-8674(00)80215-9.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D. 1997. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89:357–364. http://dx.doi.org/10.1016/S0092-8674(00)80216-0.
   PubMedGoogle Scholar
• Dovey OM, Foster CT, Conte N, Edwards SA, Edwards JM, Singh R, Vassiliou G, Bradley A, Cowley SM. 2013. Histone deacetylase (HDAC) 1 and 2 are essential for normal T cell development and genomic stability in mice. Blood 121:1335–1344. http://dx.doi.org/10.1182/blood-2012-07-441949.
   PubMedGoogle Scholar
• Hagelkruys A, Lagger S, Krahmer J, Leopoldi A, Artaker M, Pusch O, Zezula J, Weissmann S, Xie Y, Schofer C, Schlederer M, Brosch G, Matthias P, Selfridge J, Lassmann H, Knoblich JA, Seiser C. 2014. A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog. Development 141:604–616. http://dx.doi.org/10.1242/dev.100487.
   PubMedGoogle Scholar
• Winter M, Moser MA, Meunier D, Fischer C, Machat G, Mattes K, Lichtenberger BM, Brunmeir R, Weissmann S, Murko C, Humer C, Meischel T, Brosch G, Matthias P, Sibilia M, Seiser C. 2013. Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis. EMBO J 32:3176–3191. http://dx.doi.org/10.1038/emboj.2013.243.
   PubMed Web of Science ®Google Scholar
• Abel T, Zukin RS. 2008. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8:57–64. http://dx.doi.org/10.1016/j.coph.2007.12.002.
   PubMed Web of Science ®Google Scholar
• Hagelkruys A, Sawicka A, Rennmayr M, Seiser C. 2011. The biology of HDAC in cancer: the nuclear and epigenetic components. Handb Exp Pharmacol 206:13–37. http://dx.doi.org/10.1007/978-3-642-21631-2_2.
   PubMedGoogle Scholar
• Kazantsev AG, Thompson LM. 2008. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7:854–868. http://dx.doi.org/10.1038/nrd2681.
   PubMed Web of Science ®Google Scholar
• Langley B, Gensert JM, Beal MF, Ratan RR. 2005. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets CNS Neurol Disord 4:41–50. http://dx.doi.org/10.2174/1568007053005091.
   PubMedGoogle Scholar
• Lee H, Sengupta N, Villagra A, Rezai-Zadeh N, Seto E. 2006. Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation. Mol Cell Biol 26:5259–5269. http://dx.doi.org/10.1128/MCB.01971-05.
   PubMed Web of Science ®Google Scholar
• Sun Z, Feng D, Fang B, Mullican SE, You SH, Lim HW, Everett LJ, Nabel CS, Li Y, Selvakumaran V, Won KJ, Lazar MA. 2013. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor. Mol Cell 52:769–782. http://dx.doi.org/10.1016/j.molcel.2013.10.022.
   PubMed Web of Science ®Google Scholar
• Khier H, Bartl S, Schuettengruber B, Seiser C. 1999. Cloning and characterization of the mouse histone deacetylase 1 gene: integration of a retrovirus in 129SV mice. Biochim Biophys Acta 1489:365–373. http://dx.doi.org/10.1016/S0167-4781(99)00203-1.
   PubMed Web of Science ®Google Scholar
• Anders S, Pyl PT, Huber W. 2015. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31:166–169. http://dx.doi.org/10.1093/bioinformatics/btu638.
   PubMed Web of Science ®Google Scholar
• Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:621–628. http://dx.doi.org/10.1038/nmeth.1226.
   PubMed Web of Science ®Google Scholar
• Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80. http://dx.doi.org/10.1186/gb-2004-5-10-r80.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139–140. http://dx.doi.org/10.1093/bioinformatics/btp616.
   PubMed Web of Science ®Google Scholar
• Hauser C, Schuettengruber B, Bartl S, Lagger G, Seiser C. 2002. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol Cell Biol 22:7820–7830. http://dx.doi.org/10.1128/MCB.22.22.7820-7830.2002.
   PubMedGoogle Scholar
• Taplick J, Kurtev V, Lagger G, Seiser C. 1998. Histone H4 acetylation during interleukin-2 stimulation of mouse T cells. FEBS Lett 436:349–352. http://dx.doi.org/10.1016/S0014-5793(98)01164-8.
   PubMedGoogle Scholar
• Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, Schreiber SL. 1998. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci U S A 95:3519–3524. http://dx.doi.org/10.1073/pnas.95.7.3519.
   PubMedGoogle Scholar
• Lagger S, Meunier D, Mikula M, Brunmeir R, Schlederer M, Artaker M, Pusch O, Egger G, Hagelkruys A, Mikulits W, Weitzer G, Muellner EW, Susani M, Kenner L, Seiser C. 2010. Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans. EMBO J 29:3992–4007. http://dx.doi.org/10.1038/emboj.2010.264.
   PubMed Web of Science ®Google Scholar
• Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, Olson EN. 2007. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21:1790–1802. http://dx.doi.org/10.1101/gad.1563807.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C, Matthias P. 2010. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev 24:455–469. http://dx.doi.org/10.1101/gad.552310.
   PubMed Web of Science ®Google Scholar
• Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH. 2009. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55–60. http://dx.doi.org/10.1038/nature07925.
   PubMed Web of Science ®Google Scholar
• Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, Seiser C. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21:2672–2681. http://dx.doi.org/10.1093/emboj/21.11.2672.
   PubMed Web of Science ®Google Scholar
• Reichert N, Choukrallah MA, Matthias P. 2012. Multiple roles of class I HDACs in proliferation, differentiation, and development. Cell Mol Life Sci 69:2173–2187. http://dx.doi.org/10.1007/s00018-012-0921-9.
   PubMed Web of Science ®Google Scholar
• Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, Ferrari VA, Abrams CS, Gruber PJ, Epstein JA. 2007. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med 13:324–331. http://dx.doi.org/10.1038/nm1552.
   PubMed Web of Science ®Google Scholar
• Zimmermann S, Kiefer F, Prudenziati M, Spiller C, Hansen J, Floss T, Wurst W, Minucci S, Gottlicher M. 2007. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res 67:9047–9054. http://dx.doi.org/10.1158/0008-5472.CAN-07-0312.
   PubMed Web of Science ®Google Scholar
• Taplick J, Kurtev V, Kroboth K, Posch M, Lechner T, Seiser C. 2001. Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1. J Mol Biol 308:27–38. http://dx.doi.org/10.1006/jmbi.2001.4569.
   PubMed Web of Science ®Google Scholar
• Chen JL, Lin HH, Kim KJ, Lin A, Ou JH, Ann DK. 2009. PKC delta signaling: a dual role in regulating hypoxic stress-induced autophagy and apoptosis. Autophagy 5:244–246. http://dx.doi.org/10.4161/auto.5.2.7549.
   PubMed Web of Science ®Google Scholar
• Kikkawa U, Matsuzaki H, Yamamoto T. 2002. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem 132:831–839. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a003294.
   PubMed Web of Science ®Google Scholar
• Bhaskara S, Jacques V, Rusche JR, Olson EN, Cairns BR, Chandrasekharan MB. 2013. Histone deacetylases 1 and 2 maintain S-phase chromatin and DNA replication fork progression. Epigenetics Chromatin 6:27. http://dx.doi.org/10.1186/1756-8935-6-27.
   PubMed Web of Science ®Google Scholar
• Jin H, Kanthasamy A, Anantharam V, Rana A, Kanthasamy AG. 2011. Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death. J Biol Chem 286:19840–19859. http://dx.doi.org/10.1074/jbc.M110.203687.
   PubMedGoogle Scholar
• Jin H, Kanthasamy A, Harischandra DS, Kondru N, Ghosh A, Panicker N, Anantharam V, Rana A, Kanthasamy AG. 2014. Histone hyperacetylation up-regulates protein kinase Cdelta in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease. J Biol Chem 289:34743–34767. http://dx.doi.org/10.1074/jbc.M114.576702.
   PubMedGoogle Scholar
• Lahm A, Paolini C, Pallaoro M, Nardi MC, Jones P, Neddermann P, Sambucini S, Bottomley MJ, Lo Surdo P, Carfi A, Koch U, De Francesco R, Steinkuhler C, Gallinari P. 2007. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A 104:17335–17340. http://dx.doi.org/10.1073/pnas.0706487104.
   PubMed Web of Science ®Google Scholar
• Bu P, Evrard YA, Lozano G, Dent SY. 2007. Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos. Mol Cell Biol 27:3405–3416. http://dx.doi.org/10.1128/MCB.00066-07.
   PubMed Web of Science ®Google Scholar
• Kelly RD, Cowley SM. 2013. The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts. Biochem Soc Trans 41:741–749. http://dx.doi.org/10.1042/BST20130010.
   PubMed Web of Science ®Google Scholar
• Ropero S, Fraga MF, Ballestar E, Hamelin R, Yamamoto H, Boix-Chornet M, Caballero R, Alaminos M, Setien F, Paz MF, Herranz M, Palacios J, Arango D, Orntoft TF, Aaltonen LA, Schwartz S, Jr, Esteller M. 2006. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet 38:566–569. http://dx.doi.org/10.1038/ng1773.
   PubMed Web of Science ®Google Scholar
• Deardorff MA, Bando M, Nakato R, Watrin E, Itoh T, Minamino M, Saitoh K, Komata M, Katou Y, Clark D, Cole KE, De Baere E, Decroos C, Di Donato N, Ernst S, Francey LJ, Gyftodimou Y, Hirashima K, Hullings M, Ishikawa Y, Jaulin C, Kaur M, Kiyono T, Lombardi PM, Magnaghi-Jaulin L, Mortier GR, Nozaki N, Petersen MB, Seimiya H, Siu VM, Suzuki Y, Takagaki K, Wilde JJ, Willems PJ, Prigent C, Gillessen-Kaesbach G, Christianson DW, Kaiser FJ, Jackson LG, Hirota T, Krantz ID, Shirahige K. 2012. HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle. Nature 489:313–317. http://dx.doi.org/10.1038/nature11316.
   PubMed Web of Science ®Google Scholar
• Decroos C, Bowman CM, Moser JA, Christianson KE, Deardorff MA, Christianson DW. 2014. Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange syndrome spectrum disorders. ACS Chem Biol 9:2157–2164. http://dx.doi.org/10.1021/cb5003762.
   PubMedGoogle Scholar